Literature DB >> 28302372

Experiences during newborn screening for glutaric aciduria type 1: Diagnosis, treatment, genotype, phenotype, and outcomes.

Fang-Chih Tsai1, Han-Jui Lee2, An-Guor Wang3, Shu-Chen Hsieh1, Yung-Hsiu Lu4, Ming-Che Lee5, Ju-Shan Pai1, Tzu-Hung Chu1, Chia-Feng Yang6, Ting-Rong Hsu4, Chih-Jou Lai7, Ming-Tzu Tsai1, Ping-Hsun Ho1, Min-Chieh Lin8, Ling-Yee Cheng7, Ya-Chin Chuang7, Dau-Ming Niu9.   

Abstract

BACKGROUND: Glutaric aciduria type 1 (GA-1) is an organic acidemia with potentially severe neurological sequelae. In Taiwan, newborn screening (NBS) for GA-1 began in 2001, but large-scale reporting is lacking. This study describes Taiwan's largest newborn screening population to date.
METHODS: Between 2001 and 2015, 1,490,636 newborns were screened for GA-1. Confirmatory examinations included the carnitine loading test. Confirmed patients were treated with a low lysine diet, carnitine, and high-energy intake during illness. Clinical, laboratory, and neuroimaging data were analyzed.
RESULTS: Fourteen newborns were diagnosed with GA-1 (incidence: 1/106,474). C5DC concentration was clearly increased after carnitine loading in the affected newborns, but not in false-positive newborns (p = 0.004), indicating that this test is useful as an adjuvant diagnostic method. Eleven patients followed in our hospital were enrolled, namely nine NBS patients and two patients diagnosed clinically. IVS10-2A>C was the most common mutation. Two novel mutations (T36fs and N291K) were identified. Pendular nystagmus was found in two pediatric GA-1 patients. The corresponding pathology was optic atrophy in one patient, but remained undetermined in the other patient. The frequency of encephalopathic crisis decreased substantially following NBS. Among patients diagnosed by NBS, cognitive functioning was better among patients with good compliance than patients with poor compliance (p = 0.03). Abnormalities were detected by brain MRI including diffusion-weighted imaging and apparent diffusion coefficient maps; these affected various brain regions at different stages of the disease. Basal ganglion injuries occurred after an encephalopathic crisis. White matter disease was prevalent among older patients, either with or without an encephalopathic crisis.
CONCLUSION: Early diagnosis by newborn screening followed by full compliance with treatment guidelines is important to a good outcome.
Copyright © 2017. Published by Elsevier Taiwan LLC.

Entities:  

Keywords:  Taiwan; glutaric aciduria type 1; newborn screening; nystagmus; optic atrophy

Mesh:

Substances:

Year:  2017        PMID: 28302372     DOI: 10.1016/j.jcma.2016.07.006

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  5 in total

Review 1.  Food triggers and inherited metabolic disorders: a challenge to the pediatrician.

Authors:  Evelina Maines; Annunziata Di Palma; Alberto Burlina
Journal:  Ital J Pediatr       Date:  2018-01-25       Impact factor: 2.638

2.  What are the information needs of parents caring for a child with Glutaric aciduria type 1?

Authors:  Hilary Piercy; Mildrid Yeo; Sufin Yap; Anthony R Hart
Journal:  BMC Pediatr       Date:  2019-10-13       Impact factor: 2.125

3.  Audiological and otologic manifestations of glutaric aciduria type I.

Authors:  Yen-Chi Chen; Chii-Yuan Huang; Yen-Ting Lee; Chia-Hung Wu; Sheng-Kai Chang; Hsiu-Lien Cheng; Po-Hsiung Chang; Dau-Ming Niu; Yen-Fu Cheng
Journal:  Orphanet J Rare Dis       Date:  2020-12-01       Impact factor: 4.123

4.  Enlargement of the Optic Chiasm: A Novel Imaging Finding in Glutaric Aciduria Type 1.

Authors:  A A Ntorkou; J Daire; F Renaldo; D Doummar; M Alison; M Schiff; M Elmaleh-Bergès
Journal:  AJNR Am J Neuroradiol       Date:  2021-07-08       Impact factor: 4.966

5.  The biochemical subtype is a predictor for cognitive function in glutaric aciduria type 1: a national prospective follow-up study.

Authors:  E M Charlotte Märtner; Eva Thimm; Philipp Guder; Katharina A Schiergens; Frank Rutsch; Sylvia Roloff; Iris Marquardt; Anibh M Das; Peter Freisinger; Sarah C Grünert; Johannes Krämer; Matthias R Baumgartner; Skadi Beblo; Claudia Haase; Andrea Dieckmann; Martin Lindner; Andrea Näke; Georg F Hoffmann; Chris Mühlhausen; Magdalena Walter; Sven F Garbade; Esther M Maier; Stefan Kölker; Nikolas Boy
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.